Healthcare Reform Law: Five Strategy Decisions to Make Now
A phase-by-phase approach to addressing the critical aspects of the bill impacting Biopharma and Medical Device Companies.
A round table discussion moderated by Ron Kraus, Vice President, Global Customer Strategy, PAREXEL Consulting.
Panelists:
Saurabh Aggarwal, PhD, Principal Consultant,
Reimbursement & Market Access, PAREXEL Consulting
Paul Bridges, PhD, Vice President, Global Product Development, PAREXEL Consulting
Chuck Stevens, VP & GM, Reimbursement & Market Access, PAREXEL Consulting
Ramita Tandon, Senior Director, Late Phase, PAREXEL Clinical Research
To view the webcast
Click here